Ads
related to: nih clinical trials
Search results
Immunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A...
NewMediaWire via Yahoo Finance· 6 days agoUS FDA-IND 131300 (ABV-1702)FREMONT, CA - (NewMediaWire) - May 24, 2024 - ABVC BioPharma, Inc....
KU wins $11M federal grant to create new center focusing on the key data behind women’s health
Lawrence Journal-World· 2 days agoThe following KU faculty members have been named as research leaders or directors at KU's new center...
Stallergenes Greer Foundation Announces Winners of 2023 Science Awards for Allergy
Morningstar· 3 days agoStallergenes Greer Foundation Announces Winners of 2023 Science Awards for Allergy The Stallergenes Greer Foundation, dedicated to fostering innovation and precision medicine in the field of ...
Positive One-Year Data from Phase 2 Study of Pegcetacoplan in Post-Transplant Recurrence of C3G and...
Morningstar· 6 days agoApellis Pharmaceuticals, Inc. (Nasdaq: APLS) and Sobi® (STO:SOBI) today announced positive one-year results from the Phase 2 NOBLE study investigating systemic pegcetacoplan, a targeted C3 therapy ...
HI-Bio Announces Positive Results from Phase 2 Study of Felzartamab for Late Antibody-Mediated...
WJTV Jackson· 5 days ago82% (n=9/11) of patients on felzartamab experienced resolution of antibody-mediated rejection per Banff criteria on biopsy at 24 weeks versus 20% (n=2/10) who received placebo, and patients ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoASRI Expands Global Reach with Patent Filings for Innovative Empathogens, Tryptamines and Phenylalkylamines PR Newswire LAFAYETTE, Calif., May 28, 2024 LAFAYETTE, Calif., May 28, 2024 /PRNewswire/ -- Established on Bicycle Day in 2021 by Dr. Nicholas
Immunity Boosting Combination Therapy for Myelodysplastic Syndrome (pre-Leukemia) Treatment: A...
Digital Journal· 6 days agoFREMONT, CA - (NewMediaWire) - May 24, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoThe idea for this work came from LGBTQ+ stakeholder partners, who identified improving the well-being of cancer caregivers as a top priority for research and...
Lexaria Bioscience (NASDAQ: LEXX) Concludes First Dosing for its Second GLP-1 Human Pilot Study
Digital Journal· 15 hours agoNorth of Soledar, Ukrainians yearn for peace Carlo Marks talks about his new Hallmark movie ‘The Wedding Veil Inspiration’ Musk faces US fraud trial over Tesla tweet Heat ...
In communities of color, long-covid patients are tired of being sick and neglected
Washington Post via Yahoo News· 1 day agoA mild covid infection at the start of the pandemic has thrown Jeanine Hays’s immune system out of...